- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02480504
Effects of a 5:2 Diet on Weight Loss and Cardiovascular Risk Factors in Obesity
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: The optimal diet for treating obesity and cardiovascular disease (CVD) risk is still not clarified. Could a five plus two diet, a form of intermittent energy restriction lead to good adherence, similar weight loss and reduction in CVD risk factors as a isocaloric continuous energy restrictions in obese subjects.
Methods: The study is a randomized controlled clinical trial in 120 men and women between 21 to 70 years with BMI (BMI 30-45 kg/m2), stable weight within ±3 kg last 3 months and 1 additional metabolic syndrome risk component.
Dietary intervention: Randomization will be to one of two diet groups. Participants in the intervention group will follow av 5:2 diet and participants in the control group will follow an isocaloric continuous energy restriction.
Primary research question: Compare the effect on weight reduction of intermittent energy restriction and a isocaloric continuous energy restriction in obese subjects? Secondary research questions Compare the effect of intermittent energy restriction and an isocaloric continuous energy restriction on cardiometabolic risk factors and tolerability and safety in obese subjects. The project consist of to randomized controlled clinical trials.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Oslo, Norway, 0424
- Oslo Universitetssykehus, Ullevål, avdeling for preventiv kardiologi
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Men and women between 21 to 70 years.
- BMI (BMI 30-45 kg/m2).
- stable weight within ±3 kg last 3 months.
- 1 additional metabolic syndrome risk component.
Exclusion Criteria:
- Diabetes if treated with insulin or incretin analogues.
- History of bariatric surgery.
- Use of antiobesity drugs or supplements.
- Eating disorder.
- Psychiatric illness that contributes to difficulties with study procedures.
- Alcohol or drug abuse.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: intermittent energy restriction
dietary intervention, intermittent energy restriction.
Participants in the experimental group will follow av 5:2 diet and consume a very low calorie diet providing 400 (females) to 600 (males) calories of energy to days a week and for an average male participant, this will reduce energy intake approximately 22%.
|
Randomized clinical trial
|
|
Active Comparator: continuous energy restriction
dietary intervention, continuous energy restrictions.Participants in the active comparator group will be asked to reduce daily energy intake by 22-23%
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
weight reduction
Time Frame: 1 year
|
Compare the effect on weight reduction of intermittent energy restriction and a isocaloric continuous energy restriction in obese subjects
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
cholesterol
Time Frame: 1 year
|
Compare the effect of intermittent energy restriction and isocaloric contiuous energy restriction on cholesterol
|
1 year
|
|
adverse events
Time Frame: 1 year
|
Compare the effect of intermittent energy restriction and an isocaloric continuous energy restriction on cardiometabolic risk factors and tolerability and safety in obese subjects
|
1 year
|
|
blood pressure
Time Frame: 1 year
|
Compare the effect of intermittent energy restriction and isocaloric continuous energy restriction on blood pressure
|
1 year
|
|
fasting glucose
Time Frame: 1 year
|
Compare the effect of intermittent energy restriction and isocaloric continuous energy restriction on fasting glucose
|
1 year
|
|
triglycerides
Time Frame: 1 year
|
Compare the effect of intermittent energy restriction and isocaloric contiuous energy restriction on fasting triglycerides
|
1 year
|
|
HbA1c
Time Frame: 1 year
|
Compare the effect of intermittent energy restriction and isocaloric contiuous energy restriction on HbA1c
|
1 year
|
|
C-reactive protein (CRP)
Time Frame: 1 year
|
Compare the effect of intermittent energy restriction and isocaloric contiuous energy restriction on CRP
|
1 year
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Allaf M, Elghazaly H, Mohamed OG, Fareen MFK, Zaman S, Salmasi AM, Tsilidis K, Dehghan A. Intermittent fasting for the prevention of cardiovascular disease. Cochrane Database Syst Rev. 2021 Jan 29;1(1):CD013496. doi: 10.1002/14651858.CD013496.pub2.
- Sundfor TM, Svendsen M, Tonstad S. Effect of intermittent versus continuous energy restriction on weight loss, maintenance and cardiometabolic risk: A randomized 1-year trial. Nutr Metab Cardiovasc Dis. 2018 Jul;28(7):698-706. doi: 10.1016/j.numecd.2018.03.009. Epub 2018 Mar 29.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2014/1702 (REK)
- 1702 (REK (The national commitees for research ethics in Norway))
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on dietary intervention intermittent energy restriction
-
King's College LondonMedical Research Council; Mars, Inc.CompletedAging | Cognitive DeclineUnited Kingdom
-
NHS Greater Glasgow and ClydeUniversity of GlasgowCompleted
-
Universidade do PortoUniversity of LisbonActive, not recruitingObesity | Weight LossPortugal
-
King's College LondonLighterLife (UK) LtdCompletedObesity, AbdominalUnited Kingdom
-
University of NottinghamCompletedWeight LossUnited Kingdom
-
Ohio State UniversityNational Psoriasis FoundationCompletedPsoriasis | Psoriatic ArthritisUnited States
-
Texas Tech UniversityCompleted
-
University of ArizonaCompleted
-
University of LeedsCompletedAppetitive BehaviorUnited Kingdom
-
Armed Police Force Hospital, NepalNot yet recruitingOverweight and ObesityNepal